Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA®) to the reference product (Humira®) in patients with active rheumatoid arthritis.
Jamshidi A, Gharibdoost F, Vojdanian M, Soroosh SG, Soroush M, Ahmadzadeh A, Nazarinia MA, Mousavi M, Karimzadeh H, Shakibi MR, Rezaieyazdi Z, Sahebari M, Hajiabbasi A, Ebrahimi AA, Mahjourian N, Rashti AM. Jamshidi A, et al. Among authors: hajiabbasi a. Arthritis Res Ther. 2017 Jul 20;19(1):168. doi: 10.1186/s13075-017-1371-4. Arthritis Res Ther. 2017. PMID: 28728599 Free PMC article. Clinical Trial.
Efficacy and safety of the biosimilar denosumab candidate (Arylia) compared to the reference product (Prolia®) in postmenopausal osteoporosis: a phase III, randomized, two-armed, double-blind, parallel, active-controlled, and noninferiority clinical trial.
Jamshidi A, Vojdanian M, Soroush M, Akbarian M, Aghaei M, Hajiabbasi A, Mirfeizi Z, Khabbazi A, Alishiri G, Haghighi A, Salimzadeh A, Karimzadeh H, Shirani F, Fard MRH, Nazarinia M, Soroosh S, Anjidani N, Gharibdoost F. Jamshidi A, et al. Among authors: hajiabbasi a. Arthritis Res Ther. 2022 Jun 30;24(1):161. doi: 10.1186/s13075-022-02840-8. Arthritis Res Ther. 2022. PMID: 35773713 Free PMC article. Clinical Trial.
Comparison of clinicodemographic characteristics and pattern of vascular involvement in 126 patients with Takayasu arteritis: a report from Iran and Turkey.
Tamartash Z, Javinani A, Pehlivan Y, Coskun BN, Yekta RA, Dalkilic E, Yağız B, Khavandgar N, Pournazari M, Hajiabbasi A, Sakar O, Zayeni H, Masoleh IS, Shakibi MR, Yazdi F, Mahmoudi M, Masoumi M, Mohammadzadegan AM, Sima F, Salehi S, Faezi ST, Jamshidi AR, Kavosi H. Tamartash Z, et al. Among authors: hajiabbasi a. Reumatismo. 2022 Dec 29;74(3). doi: 10.4081/reumatismo.2022.1487. Reumatismo. 2022. PMID: 36580066 Free article.
Association of Killer Cell Immunoglobulin-like Receptor (KIR) Genes and their HLA Ligands with Susceptibility to Takayasu Arteritis in the Iranian Population.
Beigmohammadi F, Aslani S, Kavosi H, Javinani A, Mostafaei S, Pournazari M, Tasorian B, Farhadi E, Hajiabbasi A, Zayeni H, Khabbazi A, Jamshidi A, Shenavar Masooleh I, Tamartash Z, Vojdanian M, Mahmoudi M. Beigmohammadi F, et al. Among authors: hajiabbasi a. Iran J Allergy Asthma Immunol. 2023 Feb 20;22(1):25-33. doi: 10.18502/ijaai.v22i1.12003. Iran J Allergy Asthma Immunol. 2023. PMID: 37002628 Free article.
Cardiac involvement in rheumatoid arthritis: A cross-sectional study in Iran.
Shenavar Masooleh I, Zayeni H, Haji-Abbasi A, Azarpira M, Hadian A, Hassankhani A, Ghavidel Parsa B. Shenavar Masooleh I, et al. Indian Heart J. 2016 May-Jun;68(3):332-5. doi: 10.1016/j.ihj.2015.08.030. Epub 2016 Jan 12. Indian Heart J. 2016. PMID: 27316486 Free PMC article.
17 results